Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 29 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 8598203

    Treatment of Crohn's disease with laquinimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  2. US 8598322

    Anti CEACAM1 antibodies and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  3. US 8592442

    Nilotinib HCl crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  4. US 8580819

    Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  5. US 8569379

    Use of rasagiline for the treatment of olfactory dysfunction

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  6. US 8563618

    Skin external preparation having excellent stability

    KURARAY CO., LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  7. US 8563503

    Antibiotic, its nucleotide sequence, methods of construction and uses thereof

    PROTEIN DESIGN LAB, LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  8. US 8557790

    A3 adenoside receptor agonists for the reduction of intraocular pressure

    CAN-FITE BIOPHARMA LTD. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  9. US 8552147

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  10. US 8545885

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  11. US 8541373

    BChE albumin fusions for the treatment of cocaine abuse

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  12. US 8541182

    Biological marker for inflammation

    CAN-FITE BIOPHARMA LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  13. US 8541185

    Method of predicting responsiveness to autologous adoptive cell transfer therapy

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  14. US 8536149

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted
  15. US 8529907

    Methods of treating ophthalmic disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  16. US 8512258

    Breath test device and method

    EXALENZ BIOSCIENCE LTD. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  17. US 8507463

    Nucleotide analogue prodrug and the preparation thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  18. US 8501766

    Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  19. US 8497241

    WNT10-derived peptide and use thereof

    CAREGEN CO., LTD. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted
  20. US 8486433

    Antibacterial deodorant

    JGC Catalysts and Chemicals Ltd. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted
  21. US 8487097

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted
  22. US 8481511

    Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process

    Hainan Hdeton Science and Technology Co., Ltd. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted
  23. US 8470344

    Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  24. US 8469899

    Management of gastro-intestinal disorders

    EXALENZ BIOSCIENCE LTD. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted